Commentary: Outcome Predictors of Biopsy-Proven Myeloperoxidase-Anti-Neutrophil Cytoplasmic Antibody-Associated Glomerulonephritis

Front Immunol. 2021 Jun 2:12:691179. doi: 10.3389/fimmu.2021.691179. eCollection 2021.

Authors

Samuel Wacrenier^{1

2

3}, Charlotte Boud'hors¹, Giorgina Piccoli², Jean-François Augusto^{1

3}, Benoit Brilland^{1

3}

Affiliations

¹ Service de Néphrologie-Dialyse-Transplantation, Université d'Angers, CHU Angers, Angers, France.
² Service de Néphrologie, Centre Hospitalier du Mans, Le Mans, France.
³ Université d'Angers, INSERM, CRCINA, Angers, France.

No abstract available

Keywords: ANCA-associated vasculitis; death; end stage kidney disease; glomerulonephritis; predictor.

Publication types

Comment

MeSH terms

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis* / diagnosis
Antibodies, Antineutrophil Cytoplasmic
Biopsy
Glomerulonephritis* / diagnosis
Humans
Peroxidase

Substances

Antibodies, Antineutrophil Cytoplasmic
Peroxidase